Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1

Journal of Clinical Investigation

Volumn 102, Issue 8, 1998, Pages 1540-1550

  Moriuchi, Masako ^a,b   Moriuchi, Hiroyuki ^a,c   Turner, Wille ^b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Chemokine receptors; Chemokines; Lipoarabinomannan; Lipopolysaccharide; Lipoteichoic acid

Indexed keywords

BACTERIAL ANTIGEN; CHEMOKINE; CYTOKINE; INTERFERON;

ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MACROPHAGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0032532388     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4151     Document Type: Article

References (83)

1. Fauci, A.S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:529-534.
2. Orenstein, J.M., C. Fox, and S.M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science. 276:1857-1861.
3. Asjø, B., J. Albert, A. Karlsson, L. Morfeldt-Månson, G. Biberfeld, K. Lidman, and E.M. Fenyø. 1986. Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet, ii: 660-662.
4. Cheng-Mayer, C., D. Seto, M. Tateno, and J.A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science. 240:80-82.
5. Cheng-Mayer, C.,T. Shioda, and J.A. Levy. 1991. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J. Virol. 65:6931-6941.
6. Connor, R.I., K.E. Sheridan, C. Ceradini, S. Choe, and N.R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:621-628.
7. Fiore, J.R., A. Bjorndal, K. Aperia-Peike, M. Di Stefano, G. Angarano, G. Pastre, H. Gaines, E.M. Fenyo, and J. Albert. 1994. The biological phenotype of HIV-1 retained during and after sexual transmission. Virology. 204:297-303.
8. Scarlatti, G., V. Hodara, P. Rossi, L. Muggiassca, A. Bucceri, J. Albert, and E.M. Fenyo. 1993. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology. 197: 624-629.
9. van't Wout, A.B., N.A. Kootstra, G.A. Mulder-Kampinga, N. Albrectvan Lent, H.J. Scherpbier, J. Veenstra, K. Boer, R.A. Coutinho, F. Miedema, and H. Schuitemaker. 1994. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parental, and vertical transmission. J. Clin. Invest. 94:2060-2067.
10. Zhu, T., H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup, and D.D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261:1179-1181.
11. Wahl, S.M., and J.M. Orenstein. 1997. Immune stimulation and HIV-1 viral replication. J. Leukoc. Biol. 62:67-71.
12. Ensoli, B., P. Lusso, F. Schachter, S.F. Josephs, J. Rappaport, F. Negro, R.C. Gallo, and F. Wong-Staal. 1989. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J. 8:3019-3027.
13. Gendelman, H.E., W. Phelps, L. Feigenbaum, J.M. Ostrove, A. Adachi, P.M. Howley, G. Khoury, H.S. Ginsberg, and M.A. Martin. 1986. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc. Natl. Acad. Sci. USA. 83:9759-9763.
14. Scala, G., I. Quinto, M.R. Ruocco, M. Mallardo, C. Ambrosino, B. Squitieri, P. Tassone, and S. Venuta. 1993. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67:2853-2861.
15. Siekevitz, M., S.F. Josephs. M. Dukovich, N. Peffer, F. Wong-Staal, and W.R. Greene. 1987. Activation of the HIV-1 LTR by T cell mitogens and transactivator protein of HTLV-I. Science. 238:1575-1578.
16. Lederman, M.M., D.L. Georges, D.J. Kusner, P. Mudido, C.-Z. Giam, and Z. Toossi. 1994. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 7:727-733.
17. Gazzinelli, R.T., A. Sher, A. Cheever, S. Gerstberger, M. A. Martin, and P. Dickie. 1996. Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo. J. Exp. Med. 183:1645-1655.
18. Bagasra, O., S.D. Wright, T. Seshamma, J.W. Oakes, and R.J. Pomerantz. 1992. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 89:6285-6289.
19. Pomerantz, R.J., M.B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253-261.
20. Bernstein, M.S., S.E. Tong-Starksen, and R.M. Locksley. 1991. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. J. Clin. Invest. 88:540-545.
21. Kornbluth, R.S., P.S. Oh, J.R. Munis, P.H. Cleveland, and D.D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1137-1151.
22. Verani, A., G. Scarlatti, M. Comar, E. Tresoldi, S. Polo, M. Giacca, P. Lusso, A.G. Siccardi, and D. Vercelli. 1997. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185:805-816.
23. Alkhatib, G., C. Combadiere, C.C Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1996. CC CKR5: a RANTHS, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1955-1958.
24. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
25. Deng, D., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R.E. Sutton, C.M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:661-666.
26. Doranz, B.J., J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Dom. 1996. A dual-tropic primary HIV-1 isolate that uses Fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1149-1158.
27. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:667-673.
28. Feng, Y., C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science. 272:872-877.
29. Tersmette, M., R.E.Y. Goede, B.J.M. Al, I.N. Winkler, R.A. Cuypers, H.T. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
30. Tersmette, M., R.A. Gruters, F. De Wolf, R.E.Y. De Goede, J.M.A. Lange, P.T.A. Schellekens, J. Goudsmit, H.G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
31. + T-cell-derived factor(s). but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA. 93:15341-15345.
32. Adachi, A., H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovtrus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
33. Peden, K.W.C., and M.A. Martin. 1995. Virological and molecular genetic techniques for studies of established HIV isolates. In HIV. A Practical Approach. Vol. 1. Virology and Immunology. J. Karn, editor. Oxford University Press, Oxford, UK.
34. Collman, R., J.W. Balliet, S.A. Gregory, H. Fiedman, D.L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-7521.
35. Theodore, T.S., G. Englund, A. Buckler-White, C.E. Buckler, M.A. Martin, and K.W. Peden. 1996. Construction and characterization of a stable-full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res. Hum. Retroviruses. 12:191-194.
36. Moriuchi, H., M. Moriuchi, J. Arthos. J. Hoxie, and A.S. Fauci. 1997a. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1. J. Virol. 71:9664-9671.
37. Kusunoki, T., E. Hailman, T.S.-C. Juan, H.S. Lichenstein, and S.D. Wright. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182:1673-1682.
38. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1997b. NF-κB potently upregulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:3483-3491.
39. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1997c. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J. Immunol. 159:5441-5449.
40. Moriuchi, M., H. Moriuchi, W. Turner, and A.S. Fauci. 1997d. Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. J. Immunol. 159:4322-4329.
41. Moriuchi, M., H. Moriuchi, S.E. Straus, and J.I. Cohen. 1994. Varicellazoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology. 200:297-300.
42. Gendelman, H.E., J.M. Orenstein, M.A. Martin, C. Ferrua, R. Mitra, T. Phipps, L.A. Wahl, H.C. Lane, A.S. Fauci, D.S. Burke, et al. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1428-1441.
43. Schuitemaker, H., N.A. Koostar, R.E.Y. De Goede, F. De Wolf, F. Miedema, and M. Tersmette. 1991. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65:356-363.
44. Fouchier, R.A.M., M. Brouwer, N.A. Koostra, H.G. Huisman, and H. Schuitemaker. 1994. HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle. J. Clin. Invest. 94:1806-1814.
45. Valentin, A., J. Albert, E.M. Fenyo, and B. Asjo. 1994. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68:6684-6689.
46. Stent, G., G.-B. Joe, P. Kierulf, and B. Asjo. 1997. Macrophage tropism: fact or fiction? J. Leukocyte Biol. 62:4-11.
47. Roach, T.I.A., C.H. Barton, D. Chatterjee, and J.M. Blackwell. 1993. Macrophage activation: lipoarabinomannan (LAM) from avirulent and virulent strains of Mycobacterium tuberculosis differently induces the early genes c-fos. KC, JE, and TNF-α. J. Immunol. 150:1886.
48. Roach, T.I.A., C.H. Barton, F.Y. Liew, and J.M. Blackwell. 1995. Opposing effects of interferon-γ on iNOS and interleukin-10 expression in lipopolysaccharide-and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology. 85:106-113.
49. Pugin, J., D. Heumann, A. Tomasz, V.V. Kravchenko, Y. Akamatsu, M. Nishijima, M.P. Glauser, P.S.Tobias, and R.J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity. 1:509-516.
50. Reiner, N.E. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection, Immunol. Today. 15:374-381.
51. Poli, G., and A.S. Fauci. 1995. A role of cytokine in the pathogenesis of human immunodeficiency virus infection. In Human Cytokines: Their Role in Disease and Therapy. B. Aggarwahl and R. Puri, editors. Blackwell Science, Cambridge, MA. 421-449.
52. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1431.
53. Kitchens, R.L., R.J. Ulevitch, and R.S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485.
54. Couturier, C., G. Jahns, M.D. Kazatchkine, and N. Haeffner-Cavaillon. 1992. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-α by lipopolysaccharide-stimulated human monocytes. Eur. J. Immunol. 22:1461.
55. Uehara, Y., and H. Fukazawa. 1991. Use and selectivity of herbimycin A as inhibitor of protein tyrosine kinases. In Methods in Enzymology. Vol. 201B. T. Hunter and B.M. Sefton, editors. Academic Press, London. 370-379.
56. Mustelin, T., K.M. Coggeshall, N. Isakov, and A. Altman. 1990. T cell antigen receptor mediated activation of phospholipase C requires tyrosine phosphorylation. Science. 247:1584.
57. Hidakad, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. 1984. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23:5036-5041.
58. Arcaro, A., and M.P. Wymann. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem. J. 296:297-301.
59. Shapira, L., S. Takashiba, C. Champagne, S. Amar, and T.E. Van Dyke. 1994. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-α and IL-1β production by human monocytes. J. Immunol. 153:1818-1824.
60. McKnight, A., D. Wilkinson, S. Simmons, S. Talbot, L. Picard, M. Ahuja, M. Marsh, J. A. Hoxie, and P.R. Clapham. 1997. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71:1692-1696.
61. Sica, A., A. Saccani, A. Borsatti, C.A. Power, T.N.C. Wells, W. Luini, N. Polentarutti, S. Sozzani, and A. Mantovani. 1997. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185:969-974.
62. Bleui, C.C., L. Wu, J.A. Hoxie, T.A. Springer, and C.R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differently expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA. 94:1925-1929.
63. + T cells. Science. 276:273.
64. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1998. Factors secreted by HTLV-I infected cells can enhance or inhibit replication of HIV-1 in HTLV-I uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1.J. Exp. Med. 187:1689-1697.
65. Simmons, G., P.R. Clapham, L. Picard, R.E. Offord, M.M. Rosenkilde, T.W. Schwarts, R. Buser, T.N.C. Wells, and A.E.I. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:276-279.
66. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1998. Differentiation of promonocytic U937 subclones into macrophage-like phenotypes regulates a cellular factor(s) which modulates fusion/entry of macrophage-tropic human immunodeficiency virus type 1. J. Virol. 72:3394-3400.
67. Schmidtmayerova, H., B. Sherry, and M. Bukrinsky. 1996. Chemokines and HIV replication. Nature. 382:767.
68. Wagner, L., O.O. Yang, E.A. Garcia-Zepeda, Y. Ge, S.A. Kalams, B.D. Walker, M.S. Pasternack, and A.D. Luster. 1998. β-Chemokines are released from HIV-1-specific cytoloxic T-cell granules complexed to proteoglycans. Nature. 391:908-911.
69. Proost, P., I. De Meester, D. Schols, S. Struyf, A.-M. Lambeir, A. Wuyts, G. Opdenakker, E. De Clercq, S. Scharpe, and J. Van Damme. 1998. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273:7222.
70. + T-cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA. 92:9004-9008.
71. Huang, Z.B., M.J. Potash, M. Simm, M. Shahabuddin, W. Chao, H.E. Gendelman, E. Eden, and D.J. Volsky. 1993. Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis. J. Virol. 67:6893-6896.
72. Nuovo, G.J., F. Gallery, P. MacConnell, and A. Braun. 1994. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144: 659-666.
73. Schmidtmayerova, H., M. Alfano, G. Nuovo, and M. Bukrinsky. 1998. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4-and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 72:4633-4642.
74. Valentin, A., J. Albert, E.M. Fenyo, and B. Asjo. 1994. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68:6684-6689.
75. Weissman, D., and A.S. Fauci. 1997. Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection. Clin. Microbiol. Rev. 10:358-367.
76. Zambruno, G., A. Gianetti, U. Bertazzoni, and G. Girolomoni. 1995. Langerhans cells and HIV-1 infection. Immunol. Today. 16:520-524.
77. + lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncitium-inducing isolates of human immunodeficiency virus type 1. J. Virol. 70:8758-8764.
78. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:367-377.
79. Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:722-725.
80. Dean, M., M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1856-1862.
81. Biti, R., R. French, J. Young, B. Bennetts, and G. Stewart. 1997. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 2:1240-1243.
82. O'Brien, T., C. Winkler, M. Dean, J.A. Nelson, M. Currington, N.L. Michael, and G.C. White. 1997. HIV-1 infection in a man homozygous for CCR5Δ32. Lancet. 349:1219.
83. Theodorou, I., L. Meyer, M. Magierowska, C. Katlama, and C. Rouzioux. 1997. HIV-1 infection in an individual homozygous for CCR5Δ32. Lancet. 349: 1219-1220.